CTE 1.47% 69.0¢ cryosite limited

"The Company continues to hold substantial cord blood and tissue...

  1. 1,168 Posts.
    lightbulb Created with Sketch. 585
    "The Company continues to hold substantial cord blood and tissue assets and is looking at ways to generate further long term cash and profitability from them."

    What are your thoughts on this statement?

    Glad you're finding my CTE posts useful, Resoal3,

    If I was running Cryosite and exploring ways of revamping its cord blood operations, one of the things I'd do is to learn from its main cord blood competitor, Cell Care Australia.

    It's now almost a year since Champ Private Equity secured control of Cell Care - meaning that CHAMP  has become CTE's second-ranking shareholder with 19.7%.

    As I recall it, The Australian Financial Review reported that CHAMP paid $100m+.

    The board of Cryosite would know better that I would, the answers to these questions:

    1.  Why would CHAMP buy Cell Care?

    2. Why did CHAMP pay so much?

    3. How has CHAMP improved the performance of Cell Care?

    4. If so, can CTE  emulate CHAMP?

    5. How can CHAMP directly contribute to the performance of Cryosite?

    6. Would it be appropriate to invite CHAMP to join the CTE board of three directors?

    Again, Resoal3, we may learn more at the AGM in November.
 
watchlist Created with Sketch. Add CTE (ASX) to my watchlist
(20min delay)
Last
69.0¢
Change
0.010(1.47%)
Mkt cap ! $33.67M
Open High Low Value Volume
68.0¢ 69.0¢ 68.0¢ $9.463K 13.75K

Buyers (Bids)

No. Vol. Price($)
1 1346 69.0¢
 

Sellers (Offers)

Price($) Vol. No.
75.0¢ 30000 1
View Market Depth
Last trade - 15.47pm 28/03/2024 (20 minute delay) ?
CTE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.